The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins

The most accredited hypothesis links the toxicity of amyloid proteins to their harmful effects on membrane integrity through the formation of prefibrillar-transient oligomers able to disrupt cell membranes. However, damage mechanisms necessarily assume a first step in which the amyloidogenic protein...

Full description

Saved in:
Bibliographic Details
Main Authors: Tempra, Carmelo (Author) , La Rosa, Carmelo (Author) , Lolicato, Fabio (Author)
Format: Article (Journal)
Language:English
Published: 18 February 2021
In: Chemistry and physics of lipids
Year: 2021, Volume: 236, Pages: 1-8
ISSN:1873-2941
DOI:10.1016/j.chemphyslip.2021.105061
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.chemphyslip.2021.105061
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0009308421000141
Get full text
Author Notes:Carmelo Tempra, Carmelo La Rosa, Fabio Lolicato

MARC

LEADER 00000caa a2200000 c 4500
001 1760198102
003 DE-627
005 20230428014334.0
007 cr uuu---uuuuu
008 210610s2021 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.chemphyslip.2021.105061  |2 doi 
035 |a (DE-627)1760198102 
035 |a (DE-599)KXP1760198102 
035 |a (OCoLC)1341416184 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 29  |2 sdnb 
100 1 |a Tempra, Carmelo  |e VerfasserIn  |0 (DE-588)1235147096  |0 (DE-627)1760198358  |4 aut 
245 1 4 |a The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins  |c Carmelo Tempra, Carmelo La Rosa, Fabio Lolicato 
264 1 |c 18 February 2021 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.06.2021 
520 |a The most accredited hypothesis links the toxicity of amyloid proteins to their harmful effects on membrane integrity through the formation of prefibrillar-transient oligomers able to disrupt cell membranes. However, damage mechanisms necessarily assume a first step in which the amyloidogenic protein transfers from the aqueous phase to the membrane hydrophobic core. This determinant step is still poorly understood. However, according to our lipid-chaperon hypothesis, free lipids in solution play a crucial role in facilitating this footfall. Free phospholipid concentration in the aqueous phase acts as a switch between ion channel-like pore and fibril formation, so that high free lipid concentration in solution promotes pore and repress fibril formation. Conversely, low free lipids in the solution favor fibril and repress pore formation. This behavior is due to the formation of stable lipid-protein complexes. Here, we hypothesize that the helix propensity is a fundamental requirement to fulfill the lipid-chaperon model. The alpha-helix region seems to be responsible for the binding with amphiphilic molecules fostering the proposed mechanism. Indeed, our results show the dependency of protein-lipid binding from the helical structure presence. When the helix content is substantially lower than the wild type, the contact probability decreases. Instead, if the helix is broadening, the contact probability increases. Our findings open a new perspective for in silico screening of secondary structure-targeting drugs of amyloidogenic proteins. 
650 4 |a Amyloid proteins 
650 4 |a Lipid-chaperon hypothesis 
650 4 |a Molecular dynamics simulations 
650 4 |a Protein-lipid interactions 
700 1 |a La Rosa, Carmelo  |d 1957-  |e VerfasserIn  |0 (DE-588)1235147479  |0 (DE-627)1760198641  |4 aut 
700 1 |a Lolicato, Fabio  |e VerfasserIn  |0 (DE-588)1215510608  |0 (DE-627)1726683931  |4 aut 
773 0 8 |i Enthalten in  |t Chemistry and physics of lipids  |d Amsterdam [u.a.] : Elsevier Science, 1966  |g 236(2021), Artikel-ID 105061, Seite 1-8  |h Online-Ressource  |w (DE-627)306353970  |w (DE-600)1496839-3  |w (DE-576)09408548X  |x 1873-2941  |7 nnas  |a The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins 
773 1 8 |g volume:236  |g year:2021  |g elocationid:105061  |g pages:1-8  |g extent:8  |a The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins 
856 4 0 |u https://doi.org/10.1016/j.chemphyslip.2021.105061  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0009308421000141  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210610 
993 |a Article 
994 |a 2021 
998 |g 1215510608  |a Lolicato, Fabio  |m 1215510608:Lolicato, Fabio  |d 700000  |d 711000  |e 700000PL1215510608  |e 711000PL1215510608  |k 0/700000/  |k 1/700000/711000/  |p 3  |y j 
999 |a KXP-PPN1760198102  |e 3936541892 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteinsChemistry and physics of lipids","physDesc":[{"extent":"Online-Ressource"}],"recId":"306353970","language":["eng"],"pubHistory":["1.1966 -"],"titleAlt":[{"title":"CPL"}],"title":[{"title":"Chemistry and physics of lipids","title_sort":"Chemistry and physics of lipids","subtitle":"CPL"}],"id":{"eki":["306353970"],"issn":["1873-2941"],"zdb":["1496839-3"]},"origin":[{"publisherPlace":"Amsterdam [u.a.]","publisher":"Elsevier Science","dateIssuedKey":"1966","dateIssuedDisp":"1966-"}],"part":{"year":"2021","extent":"8","volume":"236","pages":"1-8","text":"236(2021), Artikel-ID 105061, Seite 1-8"}}],"id":{"eki":["1760198102"],"doi":["10.1016/j.chemphyslip.2021.105061"]},"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"18 February 2021"}],"note":["Gesehen am 10.06.2021"],"person":[{"display":"Tempra, Carmelo","role":"aut","roleDisplay":"VerfasserIn","family":"Tempra","given":"Carmelo"},{"given":"Carmelo","family":"La Rosa","roleDisplay":"VerfasserIn","role":"aut","display":"La Rosa, Carmelo"},{"family":"Lolicato","given":"Fabio","roleDisplay":"VerfasserIn","role":"aut","display":"Lolicato, Fabio"}],"physDesc":[{"extent":"8 S."}],"recId":"1760198102","language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"name":{"displayForm":["Carmelo Tempra, Carmelo La Rosa, Fabio Lolicato"]},"title":[{"title":"The role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins","title_sort":"role of alpha-helix on the structure-targeting drug design of amyloidogenic proteins"}]} 
SRT |a TEMPRACARMROLEOFALPH1820